May 8, 2026 · Gynecologic oncology · DOI: 10.1016/j.ygyno.2026.04.018

Estrogen hormone therapy use in ovarian cancer patients under age 60 at diagnosis

Listen to this summary

The authors aimed to investigate the impact of post-diagnosis estrogen hormone therapy (EHT) on survival rates among patients diagnosed with invasive epithelial ovarian cancer (EOC) before the age of 60. Their findings indicate that EHT is associated with improved survival in patients with high-grade serous and clear cell EOC, while it correlates with worse survival in those with endometrioid EOC, suggesting that EHT may be safely used for managing menopausal symptoms in certain EOC patients but requires caution in others. Further research is necessary to explore the effects of EHT on mucinous EOC survival.

Alexandra Lukey, Ali Salmanpour, Paramdeep Kaur, Andrew Berchuck, Anne Chase, Lesa Dawson, Bronwyn Grout, Cindy McKinnon Deurloo, Jean Richardson, Gavin Stuart, Kathryn L Terry, Penelope M Webb, Malcolm C Pike, Celeste Leigh Pearce, Gillian E Hanley

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play